The Next Tech Pathway Program has now ended. 
If you have any questions, please feel free to contact us at 1.800.284.4416.

Next Tech Pathway Buy today and Get the MiniMed™ 770G for $0.*

Get Started or call 1.800.284.4416
Get started today


MiniMed 670G


Buy the MiniMedTM 670G.


check box

You'll be automatically enrolled into Next Tech Pathway as part of your purchase.




When the MiniMed™ 770G is available, we'll notify you that it's time to upgrade.




Once you confirm you are ready to move forward, we'll ship you your MiniMed 770G when available.


Our pump and continuous glucose monitor (CGM) work together to:

  • Adjust background insulin automatically every 5 minutesΔ
  • Take action to help keep your sugar levels in target range for fewer lows and highs — day and night#,Δ,1

Get Started

By submitting this form you are consenting to and confirm the following:

  • That Medtronic can communicate with you regarding our diabetes products by telephone, fax, mail and/or e-mail.
  • That Medtronic stores information, including personal health information, on systems located outside of Canada.
  • That you have read and are aware of our privacy policy.
  • That you grant Medtronic of Canada permission to send you updates on diabetes and diabetes technology.
  • You may revoke this permission at any time by emailing
  • Medtronic respects the confidentiality of personal information. We assure you we will not share your personal information, except as otherwise noted in our privacy policy.


If you've been considering a change, this could be a great time to make the move to our latest technology. Fill out the form to learn more.


The MiniMed 670G system is intended for the management of Type 1 diabetes in persons age seven and older.

Δ Refers to Auto Mode. Some user interaction required. Individual results may vary.
# Based on sensor glucose.
1. Bergenstal R, Garg S, Weinzimer S, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316(13):1407–1408.

*Terms and Conditions
The Next Tech Pathway program (the “Program”) allows eligible, enrolled participants whose MiniMed 670G system order is shipped starting on 09/01/20 (Sept 1, 2020) to be included. The last day to place an order is 01/31/21 (January 31, 2021). This Program allows for an upgrade to our next MiniMed system at $0 once licensed by Health Canada.  Eligibility dates subject to change.

To be eligible for the Program, participants must purchase a MiniMed™ 670G system and meet one of the following requirements:

  • New to Medtronic insulin pump technology; or
  • Upgrade from an out-of-warranty pump

To upgrade through the Program, all participants must agree and are subject to these terms and conditions:

  • Warranty period does not reset when you receive the new technology. The warranty period of an upgraded insulin pump and transmitter will remain the same as the warranty date of the initial pump and transmitter purchased.
  • MiniMed pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider.
  • Upon federal licensing of a new MiniMed system, it may take up to 90 days for Medtronic to contact you with the option to upgrade. Once you place your order, it may take up to 90 days to ship the new product once it is available. The Program does not guarantee prioritization of your order.
  • An upgrade through the Program can only be redeemed once during your warranty period and only for the next available technology from the date of your purchase. Your order must be placed no later than 3 months from new technology becoming licensed for sale. The Program cannot be redeemed if less than six (6) months remains on your pump warranty at the time of order.
  • The Program for the future upgrade applies to insulin pump and transmitter. CGM sensors and consumables are not included.
  • All participants should consult their healthcare provider for all therapy related decisions.
  • If your MiniMed 670G is funded through a public program, the terms and conditions of this Program may also be subject to, and modified by, public program requirements.
  • Program terms and conditions are subject to change at any time and without notice. Other restrictions may apply.